GC69085
EtDO-P4
Also known as N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]hexadecanamide
EtDO-P4 is a nanomolar-level inhibitor of glycosphingolipid (GSL) synthesis· It inhibits the activation of various receptor tyrosine kinases (RTKs) and the ERK pathway induced by EGFR· EtDO-P4 can be used for research on various types of tumors, including Burkitt's lymphoma
ChemicalCAS245329-78-6MW516.76FormulaC31H52N2O4
- CAS number
- 245329-78-6
- Molecular weight
- 516.76
- Formula
- C31H52N2O4
- InChIKey
- BBTZZVJOQCCAOR-DLFZDVPBSA-N
- Catalogue number
- GC69085
- Brand
- GLPBIO
Computed properties PubChem CID 9914532 · XLogP 8 · TPSA 71 Ų · H-bond donors 2
- XLogP
- 8
- TPSA
- 71 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 19
- Heavy atoms
- 37
SMILES CCCCCCCCCCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O
Computed descriptors from PubChem (CID 9914532), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il